## ERIE: Erie Indemnity Company - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 -0.0% below STRENGTH zone (3.0-6.0%); PEG 3.05 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($271.27)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 40 ($0.30M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- PNC Financial Servic: 10.6% (0.0%)
- Cresset Asset Manage: 10.6% (+0.0%)
- Vanguard Group Inc: 6.4% (-0.2%)
- Blackrock Inc.: 3.4% (-6.6%)
- State Street Corpora: 3.0% (-0.2%)

### Key Risks

1. Valuation stretched: PEG 3.0x requires aggressive growth execution.
2. Elevated short interest (8.6%): bears positioning against stock.
3. Long-term trend broken: trading 17.3% below SMA200.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 3.05 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 30%, ROA 15%, margin 16%). Balance sheet: low leverage (D/E 0.44). Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $15.0B |
| Beta | 0.39 |
| 52W Range | $273.59 - $456.93 |
| Short Interest | 8.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.05 |
| Forward P/E | 20.4 |
| Current P/E | 22.7 |
| YoY Growth | 11.3% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 1.7% to -0.0% (-1.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.0pp (needs >3.0% for momentum thesis). Below SMA200 (0.83x), long-term trend not supportive. MACD histogram positive (0.56), confirming momentum. RSI neutral at 46. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.03% (CS: 51) | Neutral |
| RSI_14 | 45.9 | Neutral |
| MACD Histogram | 0.56 | Bullish |
| vs SMA20 | 0.990x | Below |
| vs SMA50 | 0.964x | Below |
| vs SMA200 | 0.827x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $286.15
- **Stop Loss:** $271.27 (5.2% risk)
- **Target:** $301.03 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 60
- **Position Value:** $17,169.00
- **Portfolio %:** 17.17%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-26 (Est: $3.11)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.37 | $3.49 | +3.5% |
| 2025Q2 | $3.55 | $3.35 | -5.7% |
| 2025Q1 | $3.19 | $2.65 | -16.9% |
| 2024Q4 | $2.82 | $2.91 | +3.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*